| 2024 |
Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis |
Review essay (rassegna critica) |
Vai |
| 2024 |
The importance of arterial stiffness in pediatric patients with type 1 diabetes mellitus: What's new? |
Articolo in rivista |
Vai |
| 2024 |
Therapeutic Potential of Sodium-glucose Co-transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists for Patients with Acute Coronary Syndrome: A Review of Clinical Evidence |
Review essay (rassegna critica) |
Vai |
| 2024 |
Circadian rhythms and cancer: implications for timing in therapy |
Review essay (rassegna critica) |
Vai |
| 2024 |
Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies |
Articolo in rivista |
Vai |
| 2024 |
Retrospective study on the emotional status of healthcare workers in a COVID-19 field hospital in Oman |
Articolo in rivista |
Vai |
| 2024 |
Age-Related Changes in Insulin Resistance and Muscle Mass: Clinical Implications in Obese Older Adults |
Review essay (rassegna critica) |
Vai |
| 2024 |
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies |
Articolo in rivista |
Vai |
| 2024 |
Association Between Adequate Serum 25(OH)D Levels and Atherogenic Dyslipidemia in Young Adults |
Articolo in rivista |
Vai |
| 2024 |
The Effect of Sodium–Glucose Cotransporter Inhibitors on Renal Function as Adjunctive to Insulin in Adults with Type 1 Diabetes: An Updated Multilevel Meta-analysis of Randomized Controlled Trials |
Articolo in rivista |
Vai |
| 2024 |
Adrenal Insufficiency in Patients with Beta Thalassemia: A Meta-Analysis |
Articolo in rivista |
Vai |
| 2024 |
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure? |
Review essay (rassegna critica) |
Vai |
| 2024 |
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? |
Review essay (rassegna critica) |
Vai |
| 2024 |
The Role of Lipid Metabolism in Dyslipidemias and Atherosclerosis |
Nota o commento |
Vai |
| 2024 |
In-silico modelling of insulin secretion and pancreatic beta-cell function for clinical applications: is it worth the effort? |
Nota o commento |
Vai |
| 2024 |
Glucometabolic Efficacy of the Empagliflozin/Metformin Combination in People with Type 1 Diabetes and Increased Cardiovascular Risk: A Sub-Analysis of a Pilot Randomized Controlled Trial |
Articolo in rivista |
Vai |
| 2024 |
The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia |
Review essay (rassegna critica) |
Vai |
| 2024 |
Novel antidiabetic therapies in patients with peripheral artery disease: current perspective |
Nota o commento |
Vai |
| 2024 |
Mitigating Increased Cardiovascular Risk in Patients with Obstructive Sleep Apnea Using GLP-1 Receptor Agonists and SGLT2 Inhibitors: Hype or Hope? |
Review essay (rassegna critica) |
Vai |
| 2024 |
Emerging treatment strategies for polycystic ovary syndrome women with obesity: Focus on glucagon-like peptide-1 receptor agonists |
Articolo in rivista |
Vai |
| 2024 |
Diabetes: Recent Advances and Future Perspectives |
Nota o commento |
Vai |
| 2024 |
Ferroptosis and iron metabolism in diabetes: Pathogenesis, associated complications, and therapeutic implications |
Review essay (rassegna critica) |
Vai |
| 2024 |
Therapeutic Advances in Obesity: How Real-World Evidence Impacts Affordability Beyond Standard of Care |
Review essay (rassegna critica) |
Vai |
| 2024 |
New Advances in Metabolic Syndrome |
Nota o commento |
Vai |
| 2024 |
Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group |
Review essay (rassegna critica) |
Vai |
| 2024 |
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. |
Review essay (rassegna critica) |
Vai |
| 2024 |
Safety and efficacy of vaccinations in patients with multiple sclerosis: a systematic review |
Review essay (rassegna critica) |
Vai |
| 2024 |
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies |
Review essay (rassegna critica) |
Vai |
| 2024 |
Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome: A Modern Cinderella? |
Review essay (rassegna critica) |
Vai |
| 2024 |
Tirzepatide, a novel, dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist for the ongoing diabesity epidemic: the dawn of a new era? |
Nota o commento |
Vai |
| 2024 |
Impact of different hormones on the regulation of nitric oxide in diabetes |
Articolo in rivista |
Vai |
| 2024 |
Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity? |
Nota o commento |
Vai |
| 2024 |
Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission? |
Articolo in rivista |
Vai |
| 2024 |
The effect of SGLT2 inhibitors and GLP1 receptor agonists on arterial stiffness: A meta-analysis of randomized controlled trials |
Articolo in rivista |
Vai |
| 2024 |
Exploring the Landscape of Familial Hypercholesterolemia: Unraveling Genetic Complexity and Clinical Implications |
Nota o commento |
Vai |
| 2024 |
Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2024 |
Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment |
Articolo in rivista |
Vai |
| 2024 |
Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone |
Articolo in rivista |
Vai |
| 2024 |
The Importance of a Novel Syndemic Approach for Cardiometabolic
Diseases |
Nota o commento |
Vai |
| 2024 |
Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta‐analysis |
Articolo in rivista |
Vai |
| 2024 |
Monitoring the liver as a part of the cardio-renal-metabolic continuum – What is cooking and burning with non-invasive tests and treatment options? |
Nota o commento |
Vai |
| 2024 |
Cilostazol for the treatment of distal symmetrical polyneuropathy in diabetes mellitus: Where do we stand? |
Review essay (rassegna critica) |
Vai |
| 2024 |
Precision diabetology: Where do we stand now? |
Nota o commento |
Vai |
| 2024 |
Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbidities |
Nota o commento |
Vai |
| 2024 |
The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications |
Articolo in rivista |
Vai |
| 2023 |
Infection with Helicobacter pylori may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries |
Articolo in rivista |
Vai |
| 2023 |
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? |
Review essay (rassegna critica) |
Vai |
| 2023 |
Lipoprotein subclasses and early kidney dysfunction in young type 1 diabetes mellitus patients |
Nota o commento |
Vai |
| 2023 |
GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms |
Articolo in rivista |
Vai |
| 2023 |
Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature |
Articolo in rivista |
Vai |
| 2023 |
Has the time come to step up to "triple therapy" for the treatment of diabetic kidney disease? |
Nota o commento |
Vai |
| 2023 |
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review |
Review essay (rassegna critica) |
Vai |
| 2023 |
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review |
Nota o commento |
Vai |
| 2023 |
The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases |
Articolo in rivista |
Vai |
| 2023 |
The Role of Advanced Glycation End Products on Dyslipidemia |
Review essay (rassegna critica) |
Vai |
| 2023 |
Timing Is Important-Management of Metabolic Syndrome According to the Circadian Rhythm |
Review essay (rassegna critica) |
Vai |
| 2023 |
Tirzepatide and glucagon-like peptide-1 receptor agonists: safety always comes first! |
Nota o commento |
Vai |
| 2023 |
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials |
Articolo in rivista |
Vai |
| 2023 |
Semaglutide in Obesity: Unmet Needs in Men |
Nota o commento |
Vai |
| 2023 |
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance |
Articolo in rivista |
Vai |
| 2023 |
Editorial: Diet-microbe-host interactions in metabolic syndrome |
Nota o commento |
Vai |
| 2023 |
Effect of Glucagon-like Peptide-1 Receptor Agonists on Cardio-Metabolic Risk Factors among Obese/Overweight Individuals Treated with Antipsychotic Drug Classes: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials |
Review essay (rassegna critica) |
Vai |
| 2023 |
Epicardial, peripancreatic and other "orthotopic" excessive fat deposition in south Asians and Europeans: Are differences clinically relevant? |
Articolo in rivista |
Vai |
| 2023 |
GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now? |
Articolo in rivista |
Vai |
| 2023 |
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update |
Review essay (rassegna critica) |
Vai |
| 2023 |
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes |
Articolo in rivista |
Vai |
| 2023 |
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials |
Articolo in rivista |
Vai |
| 2023 |
A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy-A Systematic Review and Meta-Analysis |
Review essay (rassegna critica) |
Vai |
| 2023 |
Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview |
Articolo in rivista |
Vai |
| 2023 |
Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis |
Review essay (rassegna critica) |
Vai |
| 2023 |
Efficacy and safety of once-weekly versus once-daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis |
Articolo in rivista |
Vai |
| 2023 |
Efficient Generation of Chondrocytes From Bone Marrow-Derived Mesenchymal Stem Cells in a 3D Culture System: Protocol for a Practical Model for Assessing Anti-Inflammatory Therapies |
Articolo in rivista |
Vai |
| 2023 |
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP) |
Articolo in rivista |
Vai |
| 2023 |
ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON) |
Articolo in rivista |
Vai |
| 2023 |
Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk |
Review essay (rassegna critica) |
Vai |
| 2023 |
Potassium Iodide in Nuclear Accidents: Give it Timely, Swiftly and Judiciously |
Nota o commento |
Vai |
| 2023 |
PUFA treatment in patients with gestational diabetes mellitus: Lights and shadows |
Articolo in rivista |
Vai |
| 2023 |
Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus-A Real-Life Clinical Practice Study |
Articolo in rivista |
Vai |
| 2023 |
Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia |
Articolo in rivista |
Vai |
| 2023 |
Does Iodine Influence the Metabolism of Glucose? |
Articolo in rivista |
Vai |
| 2023 |
Upstream comprehensive management of individuals with diabetes with multimorbidity and frailty to act against amputation |
Articolo in rivista |
Vai |
| 2023 |
Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus |
Nota o commento |
Vai |
| 2023 |
Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation |
Articolo in rivista |
Vai |
| 2023 |
Quality of Life in People with Diabetes Mellitus and Unilateral Transtibial Amputation - Aspects of Using the Berg Balance Scale |
Articolo in rivista |
Vai |
| 2023 |
The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis |
Review essay (rassegna critica) |
Vai |
| 2023 |
Lipid Guidelines and Cardiovascular Prevention: Let’s Manage the Risk of Our Patients! |
Nota o commento |
Vai |
| 2023 |
Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study |
Articolo in rivista |
Vai |
| 2023 |
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials |
Articolo in rivista |
Vai |
| 2023 |
The legacy effect in early-stage diabetes: Don't stay by me, cardiovascular disease! |
Articolo in rivista |
Vai |
| 2023 |
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news! |
Articolo in rivista |
Vai |
| 2023 |
The Effect of Curcumin on the Gut-Brain Axis: Therapeutic Implications |
Review essay (rassegna critica) |
Vai |
| 2023 |
The effect of Spirulina supplementation on lipid profile: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials |
Articolo in rivista |
Vai |
| 2023 |
The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study |
Articolo in rivista |
Vai |
| 2023 |
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement |
Articolo in rivista |
Vai |
| 2023 |
Neurological Consequences, Mental Health, Physical Care, and Appropriate Nutrition in Long-COVID-19 |
Review essay (rassegna critica) |
Vai |
| 2023 |
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study |
Articolo in rivista |
Vai |
| 2023 |
Is subclinical cardiovascular disease linked with periodontal disease in diabetic and non-diabetic subjects? |
Articolo in rivista |
Vai |
| 2022 |
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence |
Articolo in rivista |
Vai |
| 2022 |
The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact |
Articolo in rivista |
Vai |
| 2022 |
Non-alcoholic Fatty Liver Disease, Metabolic syndrome, and Type 2 diabetes mellitus: Where do we stand today? |
Articolo in rivista |
Vai |
| 2022 |
Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagons |
Articolo in rivista |
Vai |
| 2022 |
Does the Hyperglycemia Impact on COVID-19 Outcomes Depend upon the Presence of Diabetes?—An Observational Study |
Articolo in rivista |
Vai |
| 2022 |
Advanced Glycation End Products: Do They Impair Bone Health in Diabetes? |
Nota o commento |
Vai |
| 2022 |
Current and emerging drugs for the treatment of atherosclerosis: the evidence to date |
Review essay (rassegna critica) |
Vai |
| 2022 |
Alteration in Redox Status and Lipoprotein Profile in COVID-19 Patients with Mild, Moderate, and Severe Pneumonia |
Articolo in rivista |
Vai |
| 2022 |
A New Comorbidity in Periodontitis: Fusobacterium nucleatum and Colorectal Cancer |
Review essay (rassegna critica) |
Vai |
| 2022 |
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes |
Articolo in rivista |
Vai |
| 2022 |
Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis |
Articolo in rivista |
Vai |
| 2022 |
Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment |
Nota o commento |
Vai |
| 2022 |
Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL |
Review essay (rassegna critica) |
Vai |
| 2022 |
Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes |
Nota o commento |
Vai |
| 2022 |
Effects of Gestational Diabetes Mellitus on Cholesterol Metabolism in Women with High-Risk Pregnancies: Possible Implications for Neonatal Outcome |
Articolo in rivista |
Vai |
| 2022 |
Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly |
Articolo in rivista |
Vai |
| 2022 |
Effect of Bariatric Surgery on Intima Media Thickness: A Systematic Review and Meta-Analysis |
Review essay (rassegna critica) |
Vai |
| 2022 |
Critical questions in diabetes management: What are the most compelling challenges and how can we handle them? |
Articolo in rivista |
Vai |
| 2022 |
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review |
Review essay (rassegna critica) |
Vai |
| 2022 |
Managing the Systemic Impact of Periodontitis |
Review essay (rassegna critica) |
Vai |
| 2022 |
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS) |
Articolo in rivista |
Vai |
| 2022 |
Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention |
Review essay (rassegna critica) |
Vai |
| 2022 |
Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us |
Articolo in rivista |
Vai |
| 2022 |
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence |
Review essay (rassegna critica) |
Vai |
| 2022 |
The Therapeutic Role of SGLT-2 Inhibitors in Acute Heart Failure: From Pathophysiologic Mechanisms to Clinical Evidence with Pooled Analysis of Relevant Studies across Safety and Efficacy Endpoints of Interest |
Review essay (rassegna critica) |
Vai |
| 2022 |
Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group |
Articolo in rivista |
Vai |
| 2022 |
Treatment of diabetes and heart failure: Facts and hopes |
Nota o commento |
Vai |
| 2022 |
Vitamin D in the Prevention and Treatment of Diabetic Neuropathy |
Review essay (rassegna critica) |
Vai |
| 2022 |
The regulation of efferocytosis signaling pathways and adipose tissue homeostasis in physiological conditions and obesity: Current understanding and treatment options |
Review essay (rassegna critica) |
Vai |
| 2022 |
The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel |
Review essay (rassegna critica) |
Vai |
| 2022 |
The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus |
Articolo in rivista |
Vai |
| 2022 |
Weight response to GLP-1 receptor agonists: Why women do it better? |
Nota o commento |
Vai |
| 2022 |
Metformin: Sex/Gender Differences in Its Uses and Effects-Narrative Review |
Review essay (rassegna critica) |
Vai |
| 2022 |
Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL |
Review essay (rassegna critica) |
Vai |
| 2022 |
Obesity and HFpEF |
Nota o commento |
Vai |
| 2022 |
Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients |
Nota o commento |
Vai |
| 2022 |
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study |
Articolo in rivista |
Vai |
| 2022 |
Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022) |
Review essay (rassegna critica) |
Vai |
| 2022 |
Post-COVID syndrome, inflammation, and diabetes |
Articolo in rivista |
Vai |
| 2022 |
Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions |
Review essay (rassegna critica) |
Vai |
| 2022 |
Oxidative Stress and Inflammatory Biomarkers in Patients with Diabetic Foot |
Articolo in rivista |
Vai |
| 2022 |
Role of Chemerin in Cardiovascular Diseases |
Review essay (rassegna critica) |
Vai |
| 2022 |
Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections |
Nota o commento |
Vai |
| 2022 |
The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis |
Review essay (rassegna critica) |
Vai |
| 2022 |
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) |
Review essay (rassegna critica) |
Vai |
| 2022 |
The Effects of Statin Treatment on Serum Ferritin Levels: A Systematic Review and Meta-Analysis |
Articolo in rivista |
Vai |
| 2022 |
Statins and angiogenesis in non-cardiovascular diseases |
Review essay (rassegna critica) |
Vai |
| 2022 |
The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction |
Articolo in rivista |
Vai |
| 2022 |
Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect? |
Articolo in rivista |
Vai |
| 2022 |
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes |
Review essay (rassegna critica) |
Vai |
| 2022 |
The Role of Fructose as a Cardiovascular Risk Factor: An Update |
Articolo in rivista |
Vai |
| 2022 |
The Role of the Metabolome and Non-Coding RNA on Pheochromocytomas and Paragangliomas: An Update |
Articolo in rivista |
Vai |
| 2022 |
Glycemic Variability, Glycated Hemoglobin, and Cardiovascular Complications: Still a Dilemma in Clinical Practice |
Nota o commento |
Vai |
| 2022 |
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia |
Articolo in rivista |
Vai |
| 2022 |
A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies |
Review essay (rassegna critica) |
Vai |
| 2022 |
Correlations between Diabetes Mellitus Self-Care Activities and Glycaemic Control in the Adult Population: A Cross-Sectional Study |
Articolo in rivista |
Vai |
| 2022 |
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health |
Articolo in rivista |
Vai |
| 2022 |
Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention |
Nota o commento |
Vai |
| 2021 |
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels? |
Articolo in rivista |
Vai |
| 2021 |
Novel therapeutical approaches to managing atherosclerotic risk |
Review essay (rassegna critica) |
Vai |
| 2021 |
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes |
Articolo in rivista |
Vai |
| 2021 |
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care |
Articolo in rivista |
Vai |
| 2021 |
Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study |
Articolo in rivista |
Vai |
| 2021 |
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story |
Nota o commento |
Vai |
| 2021 |
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect |
Articolo in rivista |
Vai |
| 2021 |
Reconnoitering the role of long-noncoding rnas in hypertrophic cardiomyopathy: A descriptive review |
Review essay (rassegna critica) |
Vai |
| 2021 |
Lipoproteins and cardiovascular disease: An update on the clinical significance of atherogenic small, dense LDL and new therapeutical options |
Articolo in rivista |
Vai |
| 2021 |
Postmarketing nutrivigilance safety profile: A line of dietary food supplements containing red yeast rice for dyslipidemia |
Articolo in rivista |
Vai |
| 2021 |
Exploring the role of skeletal muscle in insulin resistance: lessons from cultured cells to animal models |
Review essay (rassegna critica) |
Vai |
| 2021 |
The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP) |
Articolo in rivista |
Vai |
| 2021 |
Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel |
Articolo in rivista |
Vai |
| 2021 |
Semaglutide reduces fat accumulation in the tongue: A randomized single-blind, pilot study |
Articolo in rivista |
Vai |
| 2021 |
Cardiometabolic alterations in the interplay of covid-19 and diabetes: Current knowledge and future avenues |
Nota o commento |
Vai |
| 2021 |
Endocrinology in the time of covid-19: A rapid evolution of knowledge and care |
Nota o commento |
Vai |
| 2021 |
Crispr gene editing in lipid disorders and atherosclerosis: Mechanisms and opportunities |
Review essay (rassegna critica) |
Vai |
| 2021 |
The role of endothelium in covid-19 |
Review essay (rassegna critica) |
Vai |
| 2021 |
Post-acute COVID-19 neurological syndrome: A new medical challenge |
Articolo in rivista |
Vai |
| 2021 |
Challenges and opportunities on lipid metabolism disorders diagnosis and therapy: Novel insights and future perspective |
Nota o commento |
Vai |
| 2021 |
Metabolic syndrome: From molecular mechanisms to novel therapies |
Nota o commento |
Vai |
| 2021 |
Molecular endocrinology and metabolism in 2021: What’s new |
Nota o commento |
Vai |
| 2021 |
Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes |
Articolo in rivista |
Vai |
| 2021 |
New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications? |
Nota o commento |
Vai |
| 2021 |
Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review |
Review essay (rassegna critica) |
Vai |
| 2021 |
Glucagon-like peptide 1 and taste perception: From molecular mechanisms to potential clinical implications |
Articolo in rivista |
Vai |
| 2021 |
Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets |
Review essay (rassegna critica) |
Vai |
| 2021 |
Diabetes and colorectal cancer risk: A new look at molecular mechanisms and potential role of novel antidiabetic agents |
Review essay (rassegna critica) |
Vai |
| 2021 |
Betatrophin levels are related to the early histological findings in nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2021 |
The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism |
Articolo in rivista |
Vai |
| 2021 |
Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action |
Nota o commento |
Vai |
| 2021 |
The evolving role of fetuin‐a in nonalcoholic fatty liver disease: An overview from liver to the heart |
Review essay (rassegna critica) |
Vai |
| 2021 |
Incretin-based therapies in 2021 – Current status and perspectives for the future |
Nota o commento |
Vai |
| 2021 |
Statin intolerance: new data and further options for treatment |
Review essay (rassegna critica) |
Vai |
| 2021 |
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP) |
Articolo in rivista |
Vai |
| 2021 |
Diabetes and COVID-19: A Tale of 2 Pandemics |
Nota o commento |
Vai |
| 2021 |
LE VESCICOLE EXTRACELLULARI VEGETALI PER LO SVILUPPO DI NUOVI NUTRACEUTICI: STUDIO PRE-CLINICO E CLINICO DELLE PROPRIETÀ BIOLOGICHE DELLE VESCICOLE ISOLATE DA SUCCO DI LIMONE |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2021 |
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus |
Review essay (rassegna critica) |
Vai |
| 2021 |
Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel |
Articolo in rivista |
Vai |
| 2021 |
Long-term brain disorders in post covid-19 neurological syndrome (Pcns) patient |
Articolo in rivista |
Vai |
| 2021 |
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome |
Review essay (rassegna critica) |
Vai |
| 2021 |
Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review) |
Articolo in rivista |
Vai |
| 2020 |
Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP) |
Articolo in rivista |
Vai |
| 2020 |
Diabetes and renin-angiotensin-aldosterone system: Implications for covid-19 patients with diabetes treatment management |
Review essay (rassegna critica) |
Vai |
| 2020 |
Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy |
Lettera |
Vai |
| 2020 |
Efficacy of a fasting‐mimicking diet in functional therapy for depression: A randomised controlled pilot trial |
Articolo in rivista |
Vai |
| 2020 |
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study |
Articolo in rivista |
Vai |
| 2020 |
An overview of statin-induced myopathy and perspectives for the future |
Articolo in rivista |
Vai |
| 2020 |
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors |
Articolo in rivista |
Vai |
| 2020 |
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study |
Articolo in rivista |
Vai |
| 2020 |
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect |
Articolo in rivista |
Vai |
| 2020 |
Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies |
Articolo in rivista |
Vai |
| 2020 |
Current pharmacological treatment of painful diabetic neuropathy: A narrative review |
Review essay (rassegna critica) |
Vai |
| 2020 |
Nlrp3 inflammasome biomarker—could be the new tool for improved cardiometabolic syndrome outcome |
Review essay (rassegna critica) |
Vai |
| 2020 |
COVID-19 and diabetes management: What should be considered? |
Nota o commento |
Vai |
| 2020 |
Gut microbiota and aging-A focus on centenarians |
Articolo in rivista |
Vai |
| 2020 |
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights |
Articolo in rivista |
Vai |
| 2020 |
Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis |
Articolo in rivista |
Vai |
| 2020 |
Drug Induced Liver Injury (DILI) due to variability in monacolin K content in Red Yeast Rice (RYR): An expert opinion |
Articolo in rivista |
Vai |
| 2020 |
Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study |
Articolo in rivista |
Vai |
| 2020 |
Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management |
Nota o commento |
Vai |
| 2020 |
The Consumption of Fast Food Favors Weight Increase in Young Hellenic Navy Personnel: A 10-Year Follow-Up Study |
Articolo in rivista |
Vai |
| 2019 |
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study |
Articolo in rivista |
Vai |
| 2019 |
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study |
Articolo in rivista |
Vai |
| 2019 |
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study |
Articolo in rivista |
Vai |
| 2019 |
A NOVEL THERAPEUTIC APPROACH TO COLORECTAL CANCER IN DIABETES: ROLE OF METFORMIN AND RAPAMYCIN |
Articolo in rivista |
Vai |
| 2019 |
Gut microbiota, obesity and bariatric surgery: Current knowledge and future perspectives |
Articolo in rivista |
Vai |
| 2019 |
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children |
Nota o commento |
Vai |
| 2019 |
Effects of aging and diet on cardioprotection and cardiometabolic risk markers |
Articolo in rivista |
Vai |
| 2019 |
Advances in pharmacological treatment of type 1 diabetes during pregnancy |
Review essay (rassegna critica) |
Vai |
| 2019 |
Psoriasis and acute coronary syndrome risk |
Nota o commento |
Vai |
| 2019 |
Future perspectives of the pharmacological management of diabetic dyslipidemia |
Review essay (rassegna critica) |
Vai |
| 2018 |
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms |
Articolo in rivista |
Vai |
| 2018 |
Statins in liver disease: not only prevention of cardiovascular events |
Articolo in rivista |
Vai |
| 2018 |
Serum lipoproteins are not associated with the severity of asthma |
Articolo in rivista |
Vai |
| 2018 |
Natural approaches in metabolic syndrome management |
Review essay (rassegna critica) |
Vai |
| 2018 |
Metabolic disorders during pregnancy and postpartum cardiometabolic risk |
Articolo in rivista |
Vai |
| 2018 |
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study |
Articolo in rivista |
Vai |
| 2018 |
Management of Statin Intolerance in 2018: Still More Questions Than Answers |
Articolo in rivista |
Vai |
| 2018 |
Pharmacotherapy for gestational diabetes |
Articolo in rivista |
Vai |
| 2018 |
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases |
Articolo in rivista |
Vai |
| 2018 |
The Role of Nutraceuticals in Statin Intolerant Patients |
Articolo in rivista |
Vai |
| 2018 |
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? |
Articolo in rivista |
Vai |
| 2017 |
Oral manifestations of inflammatory bowel disease |
Articolo in rivista |
Vai |
| 2017 |
NUTRACEUTICALS IMPROVE EXPERIMENTAL COLITIS: PLACE OF CATECHINS IN THE 2,4,6-TRINITROBENZENE SULFONIC ACID MODEL RATS |
Contributo in atti di convegno pubblicato in volume |
Vai |
| 2017 |
NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet |
Articolo in rivista |
Vai |
| 2017 |
Tea catechins induce crosstalk between signaling pathways and stabilize mast cells in ulcerative colitis |
Articolo in rivista |
Vai |
| 2017 |
Nutraceuticals as an important part of combination therapy in dyslipidaemia |
Review essay (rassegna critica) |
Vai |
| 2017 |
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy |
Nota o commento |
Vai |
| 2017 |
Intensive LDL-cholesterol lowering therapy and neurocognitive function |
Articolo in rivista |
Vai |
| 2017 |
Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation |
Articolo in rivista |
Vai |
| 2017 |
PPAR agonists, atherogenic dyslipidemia and cardiovascular risk |
Review essay (rassegna critica) |
Vai |
| 2017 |
Small, dense LDL: An update |
Articolo in rivista |
Vai |
| 2016 |
In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters |
Articolo in rivista |
Vai |
| 2016 |
The effect of bergamot on dyslipidemia |
Articolo in rivista |
Vai |
| 2016 |
Anti-cytokine therapy for prevention of atherosclerosis |
Articolo in rivista |
Vai |
| 2016 |
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici |
Articolo in rivista |
Vai |
| 2016 |
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study |
Articolo in rivista |
Vai |
| 2016 |
Incretins, pregnancy, and gestational diabetes |
Articolo in rivista |
Vai |
| 2016 |
Nutraceuticals as lipid-lowering treatment in pregnancy and their effects on the metabolic syndrome |
Articolo in rivista |
Vai |
| 2016 |
IMPROVE-IT: What have we learned? |
Articolo in rivista |
Vai |
| 2016 |
Circulating miR-130a, miR-27b, and miR-210 in Patients with Peripheral Artery Disease and Their Potential Relationship with Oxidative Stress: A Pilot Study |
Articolo in rivista |
Vai |
| 2016 |
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study |
Articolo in rivista |
Vai |
| 2015 |
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. |
Articolo in rivista |
Vai |
| 2015 |
Oxidative stress markers at birth: Analyses of a neonatal population |
Articolo in rivista |
Vai |
| 2015 |
An evaluation of RVX-208 for the treatment of atherosclerosis |
Articolo in rivista |
Vai |
| 2015 |
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2015 |
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome |
Articolo in rivista |
Vai |
| 2015 |
Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment |
Articolo in rivista |
Vai |
| 2015 |
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan |
Articolo in rivista |
Vai |
| 2015 |
A Potential Link between Serum Low-Density Lipoproteins and Asthma |
Articolo in rivista |
Vai |
| 2015 |
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel |
Articolo in rivista |
Vai |
| 2015 |
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study |
Articolo in rivista |
Vai |
| 2015 |
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel |
Articolo in rivista |
Vai |
| 2014 |
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study |
Proceedings |
Vai |
| 2014 |
The effects of anti-diabetic drugs on LDL subclasses: any role for colesevelam? |
Articolo in rivista |
Vai |
| 2014 |
Treatment options for managing atherogenic dyslipidemia and fatty liver disease |
Abstract in rivista |
Vai |
| 2014 |
Association between COX-2 rs 6681231 genotype and interleukin-6 in periodontal connective tissue. A pilot study. |
Articolo in rivista |
Vai |
| 2014 |
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. |
Articolo in rivista |
Vai |
| 2014 |
Exploring lipid-related treatment options for the treatment of NASH. |
Articolo in rivista |
Vai |
| 2014 |
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. |
Articolo in rivista |
Vai |
| 2014 |
The Metabolic Syndrome and HIV Infection. |
Articolo in rivista |
Vai |
| 2014 |
Periodontitis, blood lipids and lipoproteins. |
Articolo in rivista |
Vai |
| 2014 |
New Obesity Indices and Adipokines in Normotensive Patients and Patients With Hypertension: Comparative Pilot Analysis. |
Articolo in rivista |
Vai |
| 2014 |
Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study |
Altro |
Vai |
| 2014 |
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study |
Altro |
Vai |
| 2014 |
Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men-a randomized trial |
Articolo in rivista |
Vai |
| 2014 |
High plasma levels of endothelin-1 enhance the predictive value of preclinical atherosclerosis for future cerebrovascular and cardiovascular events: a 20-year prospective study |
Articolo in rivista |
Vai |
| 2014 |
SUBFRACTIONS AND SUBPOPULATIONS OF HDL: AN UPDATE |
Articolo in rivista |
Vai |
| 2014 |
Managing the Cardiovascular Risk Associated with the Metabolic Syndrome |
Articolo in rivista |
Vai |
| 2014 |
Should low high-density lipoprotein cholesterol (HDL-C) be treated? |
Articolo in rivista |
Vai |
| 2014 |
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study |
Articolo in rivista |
Vai |
| 2014 |
Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins Be Key Mediators Of This Association? |
Articolo in rivista |
Vai |
| 2014 |
Predictors of insulin resistance in patients with obesity: a pilot study. |
Articolo in rivista |
Vai |
| 2014 |
ETC-1002: A future option for lipid disorders? |
Articolo in rivista |
Vai |
| 2014 |
Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome |
Articolo in rivista |
Vai |
| 2014 |
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis |
Articolo in rivista |
Vai |
| 2014 |
Prevalence of dyslipidemia and associated risk factors in Turkish adults. |
Articolo in rivista |
Vai |
| 2013 |
The role of fibrate treatment in dyslipidemia: an overview. |
Articolo in rivista |
Vai |
| 2013 |
Rational for statin use in psoriatic patients |
Articolo in rivista |
Vai |
| 2013 |
Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidaemia: a randomized pilot tria |
Articolo in rivista |
Vai |
| 2013 |
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy-A meta-analysis of 11 randomized controlled trials involving 21,295 participants |
Articolo in rivista |
Vai |
| 2013 |
Mipomersen: A lipid-lowering agent with a novel mechanism of action |
Articolo in rivista |
Vai |
| 2013 |
Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: Pleiotropic evidence from plasma mRNA analyses. |
Articolo in rivista |
Vai |
| 2013 |
Anti-atherogenic Effects of 17β-Estradiol |
Articolo in rivista |
Vai |
| 2013 |
Uric acid metabolism in pre-hypertension and the metabolic syndrome |
Articolo in rivista |
Vai |
| 2013 |
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? |
Articolo in rivista |
Vai |
| 2013 |
STATINS AND NEW-ONSET DIABETES |
Articolo in rivista |
Vai |
| 2013 |
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease |
Proceedings |
Vai |
| 2013 |
Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia? |
Articolo in rivista |
Vai |
| 2013 |
Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. |
Proceedings |
Vai |
| 2013 |
INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION |
Articolo in rivista |
Vai |
| 2013 |
Beyond cholesterol reduction, the pleiotropic effects of statins: is their use in cancer prevention hype or hope? |
Articolo in rivista |
Vai |
| 2013 |
Postprandial metabolism: from research to clinical practice. |
Articolo in rivista |
Vai |
| 2013 |
Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis |
Articolo in rivista |
Vai |
| 2013 |
Statin treatment in the elderly: how much do we know? |
Articolo in rivista |
Vai |
| 2013 |
Smoking and small, dense low-density lipoproteins. |
Recensione in rivista |
Vai |
| 2013 |
Serum low density lipoprotein subclasses in asthma |
Articolo in rivista |
Vai |
| 2013 |
Emerging Therapies For Raising Hdl-C And Augmenting Hdl Particle Functionality |
Articolo in rivista |
Vai |
| 2013 |
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. |
Articolo in rivista |
Vai |
| 2013 |
Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases |
Articolo in rivista |
Vai |
| 2013 |
Emerging approaches for the treatment of hypertriglyceridemia. |
Articolo in rivista |
Vai |
| 2013 |
Non-glycemic effects of pioglitazone and incretin-based therapies. |
Articolo in rivista |
Vai |
| 2013 |
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. |
Articolo in rivista |
Vai |
| 2013 |
The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy -- 5-year follow-up. |
Articolo in rivista |
Vai |
| 2013 |
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. |
Articolo in rivista |
Vai |
| 2012 |
Oxidative stress and small, dense low-density lipoproteins: Current and future perspectives |
Articolo in rivista |
Vai |
| 2012 |
Lipid-lowering therapies and achievement of LDL-cholesterol targets. |
Articolo in rivista |
Vai |
| 2012 |
Prevalence of metabolic syndrome: a comparative analysis in an unselected sample of mediterranean subjects. |
Articolo in rivista |
Vai |
| 2012 |
Clinical benefits of ezetimibe use: is absence of proof, proof of absence? |
Articolo in rivista |
Vai |
| 2012 |
The effects of statins on blood pressure: current knowledge and future perspectives. |
Articolo in rivista |
Vai |
| 2012 |
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study |
Abstract in rivista |
Vai |
| 2012 |
Medical therapy for patients with subclinical and clinical carotid atherosclerosis |
Articolo in rivista |
Vai |
| 2012 |
Size and subclasses of low-density lipoproteins in patients with obstructive sleep apnea. |
Articolo in rivista |
Vai |
| 2012 |
Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk |
Articolo in rivista |
Vai |
| 2012 |
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. |
Articolo in rivista |
Vai |
| 2012 |
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. |
Abstract in rivista |
Vai |
| 2012 |
The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly. |
Articolo in rivista |
Vai |
| 2012 |
Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study. |
Articolo in rivista |
Vai |
| 2012 |
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. |
Abstract in rivista |
Vai |
| 2012 |
The role of macrophage colony-stimulating factor in patients with acute myocardial infarction: a pilot study |
Articolo in rivista |
Vai |
| 2011 |
Heat Shock Protein-60 and Risk for Cardiovascular Disease. |
Articolo in rivista |
Vai |
| 2011 |
Effects of hypolipidemic and hypoglycemic
agents on atherogenic small, dense LDL in
Type 2 diabetes |
Articolo in rivista |
Vai |
| 2011 |
Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. |
Articolo in rivista |
Vai |
| 2011 |
High resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD. |
Articolo in rivista |
Vai |
| 2011 |
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect |
Articolo in rivista |
Vai |
| 2011 |
Evaluation of the possible contribution of antioxidants administration in metabolic syndrome. |
Articolo in rivista |
Vai |
| 2011 |
Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction |
Articolo in rivista |
Vai |
| 2011 |
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. |
Articolo in rivista |
Vai |
| 2011 |
There is more to predicting vascular disease than just established risk factors. |
Articolo in rivista |
Vai |
| 2011 |
Marshall's vein persistence: A rare and occasional finding during pacemaker implantation |
Articolo in rivista |
Vai |
| 2011 |
Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2). |
Articolo in rivista |
Vai |
| 2011 |
New lipid modulating drugs: the role of microsomal transport protein inhibitors. |
Articolo in rivista |
Vai |
| 2011 |
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. |
Articolo in rivista |
Vai |
| 2011 |
Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia. |
Articolo in rivista |
Vai |
| 2011 |
Recent insights into the relationship between inflammatory liver diseases and atherosclerosis. |
Articolo in rivista |
Vai |
| 2010 |
The role of small, dense LDL in cardiovascular risk: the contribution of the universities of Palermo and Zurich |
Capitolo o Saggio |
Vai |
| 2010 |
An update on the role of markers of inflammation in atherosclerosis |
Articolo in rivista |
Vai |
| 2010 |
Associations of fructose and glucose consumption with LDL particle size in the diet of healthy swiss men |
Abstract in rivista |
Vai |
| 2010 |
Should we measure routinely oxidized and small dense low-density lipoproteins in subjects with type 2 diabetes |
Articolo in rivista |
Vai |
| 2010 |
Ezetimibe alone or in combination with simvastatin increases small, dense low-density lipoproteins in healthy men: a randomized trial |
Articolo in rivista |
Vai |
| 2010 |
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. |
Abstract in rivista |
Vai |
| 2010 |
Lomitapide, a microsomal triglyceride transfer protein inhibitor for the treatment of hypercholesterolemia. |
Articolo in rivista |
Vai |
| 2010 |
Effects of rosiglitazone on fasting and postprandial low- and high-density lipoproteins size and subclasses in type-2 diabetes. |
Articolo in rivista |
Vai |
| 2010 |
An update on the relationships between rheumatoid arthritis and atherosclerosis. |
Articolo in rivista |
Vai |
| 2010 |
Ezetimibe with or without simvastatin increases small dense low-density lipoproteins in healthy men – a randomized trial |
Abstract in rivista |
Vai |
| 2010 |
Ethnic differences in serum lipoproteins and their determinants in South African women. |
Articolo in rivista |
Vai |
| 2010 |
Interleukin-18 levels are associated with low-density lipoproteins size. |
Articolo in rivista |
Vai |
| 2010 |
Increased plasma resistin concentrations are associated with atherogenic small, dense low-density lipoproteins in patients with type-2 diabetes |
Proceedings |
Vai |
| 2010 |
Is diabetes the cost to pay for a greater cardiovascular prevention? |
Articolo in rivista |
Vai |
| 2010 |
Effects of dark chocolate on cardiovascular risk |
Articolo in rivista |
Vai |
| 2010 |
Fasting and postprandial effects of rosiglitazone on low- and high-density lipoproteins size and subclasses in type-2 diabetes |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2009 |
Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. |
Articolo in rivista |
Vai |
| 2009 |
LDL size and subclasses in patients with abdominal aortic aneurysm |
Articolo in rivista |
Vai |
| 2009 |
Effetti della dialisi sul rischio cardiovascolare nei pazienti uremici: aumento delle particelle remnants |
Capitolo o Saggio |
Vai |
| 2009 |
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype |
Articolo in rivista |
Vai |
| 2009 |
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24 months follow-up study. |
Proceedings |
Vai |
| 2009 |
The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis |
Articolo in rivista |
Vai |
| 2009 |
Therapy with non-invasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotype. |
Articolo in rivista |
Vai |
| 2009 |
Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome |
Articolo in rivista |
Vai |
| 2009 |
The predictive role of C-reactive protein in subjects with hypertension and subclinical atherosclerosis |
Articolo in rivista |
Vai |
| 2009 |
Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and the metabolic syndrome. |
Proceedings |
Vai |
| 2009 |
Utilità della citologia nasale. |
Proceedings |
Vai |
| 2009 |
COLESTEROLO HDL E PROGRESSIONE DELLA MALATTIA ATEROSCLEROTICA |
Articolo in rivista |
Vai |
| 2009 |
Milder forms of atherogenic dyslipidemia in ovulatory vs. anovulatory polycystic ovary syndrome phenotype. |
Proceedings |
Vai |
| 2009 |
The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? |
Articolo in rivista |
Vai |
| 2009 |
Low circulating levels of HDL-cholesterol in women with PCOS and no other lipid abnormalities are associated to increased carotid intima media thickness and finding of atherogenic plaques. |
Proceedings |
Vai |
| 2009 |
Recent insights on atherogenic dyslipidemia and cardiovascular risk. |
Articolo in rivista |
Vai |
| 2009 |
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. |
Articolo in rivista |
Vai |
| 2009 |
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension |
Proceedings |
Vai |
| 2009 |
Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome |
Articolo in rivista |
Vai |
| 2009 |
When periods stop: cardiovascular consequences of PCOS. |
Capitolo o Saggio |
Vai |
| 2009 |
The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes ? |
Articolo in rivista |
Vai |
| 2009 |
Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP4-inhibitors. |
Articolo in rivista |
Vai |
| 2009 |
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. |
Proceedings |
Vai |
| 2009 |
Small dense low-density lipoproteins and peripheral arterial disease |
Altro |
Vai |
| 2009 |
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions. |
Proceedings |
Vai |
| 2009 |
Ethnic differences in serum lipids and the association with insulin sensitivity, body composition and lifestyle factors in south african women. |
Abstract in rivista |
Vai |
| 2009 |
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. |
Articolo in rivista |
Vai |
| 2009 |
Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance ? |
Articolo in rivista |
Vai |
| 2009 |
Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein. |
Proceedings |
Vai |
| 2009 |
Lipid pattern alterations in PCOS. |
Proceedings |
Vai |
| 2009 |
Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis |
Articolo in rivista |
Vai |
| 2009 |
Long-term consequences of polycystic ovary syndrome on cardiovascular risk |
Articolo in rivista |
Vai |
| 2009 |
Elevated levels of non-HDL-cholesterol are relatively uncommon in women with PCOS and generally reflect LDL-cholesterol levels. |
Proceedings |
Vai |
| 2009 |
Should we routinely measure low-density and high-density lipoprotein subclasses? |
Articolo in rivista |
Vai |
| 2009 |
Atherogenic dyslipidemia and oxidative stress: a new look |
Articolo in rivista |
Vai |
| 2009 |
Senescenza ed allergia respiratoria. |
Capitolo o Saggio |
Vai |
| 2008 |
Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. |
Articolo in rivista |
Vai |
| 2008 |
Fever of unknown origin in a mediterranean survey from a division of internal medicine: report of 91 cases during a twelve-year-period (1991-2002) |
Articolo in rivista |
Vai |
| 2008 |
Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial LDL-size and subclasses in patients with type-2 diabetes. |
Abstract in rivista |
Vai |
| 2008 |
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome? |
Articolo in rivista |
Vai |
| 2008 |
Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease |
Articolo in rivista |
Vai |
| 2008 |
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions |
Articolo in rivista |
Vai |
| 2008 |
Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency. |
Articolo in rivista |
Vai |
| 2008 |
Inflammation and atherosclerosis: recent insights and future perspectives. |
Articolo in rivista |
Vai |
| 2008 |
Do we need better lipid tools for cardiovascular risk assessment ? |
Articolo in rivista |
Vai |
| 2008 |
Non-classic forms of atherogenic dyslipidemia in women with polycystic ovary syndrome. |
Abstract in rivista |
Vai |
| 2008 |
The atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. |
Proceedings |
Vai |
| 2008 |
The atherogenic lipoprotein phenotype as predictor of cardiovascular events in patients with non-coronary forms of atherosclerosis. |
Abstract in rivista |
Vai |
| 2008 |
PREDICTION OF CEREBROVASCULAR AND CARDIOVASCULAR EVENTS IN PATIENTS WITH SUBLINICAL CAROTID ATHEROSCLEROSIS: THE ROLE OF C-REACTIVE PROTEIN |
Articolo in rivista |
Vai |
| 2008 |
Recent insights on dark chocolate consumption and cardiovascular risk. |
Articolo in rivista |
Vai |
| 2008 |
Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review. |
Articolo in rivista |
Vai |
| 2008 |
Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol |
Articolo in rivista |
Vai |
| 2008 |
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study |
Articolo in rivista |
Vai |
| 2008 |
A practical method to determine
the “atherogenic lipoprotein phenotype” |
Articolo in rivista |
Vai |
| 2008 |
Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes |
Articolo in rivista |
Vai |
| 2008 |
The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance? |
Articolo in rivista |
Vai |
| 2008 |
Small, dense low-density lipoproteins are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. |
Proceedings |
Vai |
| 2007 |
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates |
Articolo in rivista |
Vai |
| 2007 |
L’eta’ e gli elevati livelli di proteina C-reattiva e fibrinogeno sono forti predittori di eventi clinici in una popolazione di donne con aterosclerosi carotidea. |
Articolo in rivista |
Vai |
| 2007 |
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography |
Articolo in rivista |
Vai |
| 2007 |
Who needs to care about small, dense low density lipoproteins? |
Articolo in rivista |
Vai |
| 2007 |
Androgen excess and cardiovascular risk. |
Articolo in rivista |
Vai |
| 2007 |
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome |
Articolo in rivista |
Vai |
| 2007 |
Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention. |
Articolo in rivista |
Vai |
| 2007 |
Small, dense low-density-lipoproteins and the metabolic syndrome. |
Articolo in rivista |
Vai |
| 2007 |
Effects of statins, fibrates, rosuvastatin and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients. |
Articolo in rivista |
Vai |
| 2007 |
L’eta’ e gli elevati livelli di proteina C-reattiva e fibrinogeno sono forti predittori di eventi clinici in una popolazione di donne con aterosclerosi carotidea. |
Proceedings |
Vai |
| 2007 |
Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy |
Articolo in rivista |
Vai |
| 2007 |
Low-density-lipoprotein heterogeneity and the metabolic syndrome. |
Capitolo o Saggio |
Vai |
| 2007 |
The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes |
Articolo in rivista |
Vai |
| 2007 |
La presenza di disfunzione endoteliale e di aterosclerosi carotidea sono forti predittori di eventi clinici in pazienti asintomatici. |
Articolo in rivista |
Vai |
| 2007 |
An update on the role of the quality of LDL in cardiovascular risk: the contribution of the Universities of Palermo and Zurich. |
Articolo in rivista |
Vai |
| 2007 |
Therapeutic patient education in oncology: pedagogical notions for women's health and prevention. |
Articolo in rivista |
Vai |
| 2007 |
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH EARLY ONSET OF HYPERTENSION OR TYPE-II DIABETES |
Proceedings |
Vai |
| 2007 |
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY |
Proceedings |
Vai |
| 2006 |
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. |
Articolo in rivista |
Vai |
| 2006 |
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH EARLY ONSET OF HYPERTENSION OR TYPE II DIABETES. |
Proceedings |
Vai |
| 2006 |
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. |
Articolo in rivista |
Vai |
| 2006 |
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease |
Articolo in rivista |
Vai |
| 2006 |
La presenza di disfunzione endoteliale e di aterosclerosi carotidea sono forti predittori di eventi clinici in pazienti asintomatici. |
Abstract in rivista |
Vai |
| 2006 |
Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patiens with early onset of hypertension or type-2 diabetes |
Abstract in rivista |
Vai |
| 2006 |
The clinical significance of small, dense low-density lipoproteins |
Capitolo o Saggio |
Vai |
| 2006 |
The significance of low-density lipoproteins size in vascular diseases |
Articolo in rivista |
Vai |
| 2006 |
Low-density lipoprotein size and cardiovascular risk assessment. |
Articolo in rivista |
Vai |
| 2006 |
Statins, fracture risk, and bone remodeling: What is true? |
Articolo in rivista |
Vai |
| 2006 |
Effects of statins on low-density-lipoproteins size: a new role in cardiovascular prevention ? |
Articolo in rivista |
Vai |
| 2006 |
Should we measure routinely the LDL peak particle size? |
Articolo in rivista |
Vai |
| 2006 |
The role of small, dense low-density lipoproteins in non-coronary forms of atherosclerosis. |
Articolo in rivista |
Vai |
| 2006 |
The clinical relevance of low-density-lipoproteins size modulation by statins. |
Articolo in rivista |
Vai |
| 2006 |
Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. |
Articolo in rivista |
Vai |
| 2006 |
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION OR TYPE-II DIABETES |
Articolo in rivista |
Vai |
| 2006 |
L’uso di stent con sirolimus e’ significativamente associate alla riduzione della mortalita’ totale e della morbidita’ cardiovascolare sia a 6 mesi che a 12 mesi post-PTCA. |
Abstract in rivista |
Vai |
| 2006 |
Low-density-lipoproteins size and cardiovascular prevention |
Articolo in rivista |
Vai |
| 2006 |
LA PRESENZA DI ELEVATI LIVELLI DI FIBRINOGENO E PROTEINA C-REATTIVA SONO SIGNIFICATIVAMENTE ASSOCIATI ALLA PRESENZA DI ATEROSCLEROSI CAROTIDEA NEI PAZIENTI IPERTESI O DIABETICI. |
Proceedings |
Vai |
| 2006 |
Use of stents with sirolimus is significantly associated with a reduction in mortality and cardiovascular morbidity at 6- and 12-months post-PTCA |
Abstract in rivista |
Vai |
| 2006 |
ELEVATED C-REACTIVE PROTEIN LEVELS ARE A STRONG PREDICTOR OF CLINICAL EVENTS IN HYPERTENSIVE PATIENTS WITH EARLY STAGE OF ATHEROSCLEROSIS |
Proceedings |
Vai |
| 2006 |
Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with early onset of hyprtension or type-II diabetes |
Abstract in rivista |
Vai |
| 2006 |
ELEVATED C-REATIVE PROTEIN LEVELS ARE STRONG PREDICTOR OF CLINICAL EVENTS IN HYPERTENSIVE PATIENTS WITH EARLY STAGES OF
ATHEROSCLEROSIS |
Proceedings |
Vai |
| 2006 |
Elevati livelli di proteina C-reattiva sono predittivi di eventi clinici nei pazienti ipertesi con lesioni carotidee asintomatiche |
Abstract in rivista |
Vai |
| 2005 |
Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A. |
Articolo in rivista |
Vai |
| 2005 |
A case of bowel schistosomiasis that did not adhere to the endoscopic findings. |
Articolo in rivista |
Vai |
| 2005 |
Effects of combined estrogen+progestin hormone therapy on hepatic lipase and lipoprotein lipase levels |
Abstract in rivista |
Vai |
| 2005 |
Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? |
Articolo in rivista |
Vai |
| 2005 |
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels |
Articolo in rivista |
Vai |
| 2005 |
Family hystory, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study |
Articolo in rivista |
Vai |
| 2005 |
PROGNOSTIC IMPACT OF HYPERTENSION AND CAROTID LESIONS IN A FIVE YEARS FOLLOW UP |
Proceedings |
Vai |
| 2005 |
Relazione tra il size delle LDL e l’estensione della malattia vasale coronarica in 72 pazienti maschi sottoposti a coronarografia diagnostica |
Abstract in rivista |
Vai |
| 2005 |
Effects of combined estrogen+progestin hormone therapy on hepatic lipase and lipoprotein lipase levels. Atherosclerosis. 2005. 6(suppl.1) |
Proceedings |
Vai |
| 2005 |
PROGNOSTIC IMPACT OF HYPERTENSION AND CAROTIID LESIONS N A FIVE YEARS FOLLOW UP |
Proceedings |
Vai |
| 2005 |
Prognostic impact of hypertension and carotid lesions in a five years follow-up |
Abstract in rivista |
Vai |
| 2005 |
Relationship between endothelial dysfunction, intima media thickness, and other cardiovascular risk factors in asymptomatic subjects |
Abstract in rivista |
Vai |
| 2005 |
Drug eluting stents's use in patients with anatomical or clinical patterns favouring restenosis: a 6-months follow-up study |
Proceedings |
Vai |
| 2005 |
Drug eluting stents's use in patients with anatomical or clinical patterns favouring restenosis: a 6-months follow-up study. Atherosclerosis. 2005. 6(suppl.1) |
Proceedings |
Vai |
| 2005 |
FIBRINOGEN AS PREDICTOR OF MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: A 42-MONTHS FOLLOW-UP STUDY |
Articolo in rivista |
Vai |
| 2005 |
Diabetes, family hystory and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study |
Articolo in rivista |
Vai |
| 2004 |
Infection and inflammation influence the outcome of patients with asymptomatic carotid lesions |
Abstract in rivista |
Vai |
| 2004 |
Le LDL generate in fase post-prandiale dopo carico grasso presentano maggiore densita’, minore size e maggiore affinita’ per il recettore |
Abstract in rivista |
Vai |
| 2004 |
Effects “beyond-cholesterol” by statins: a 3-months therapy with simvastatin reduces the atherogenic lipoproteins in patients with premature coronary artery disease and in absence of the traditional cardiovascular risk factors. |
Articolo in rivista |
Vai |
| 2004 |
Rickttsial disease: classical and modern aspects |
Articolo in rivista |
Vai |
| 2004 |
Statins and osteoporosis: myth or reality? |
Articolo in rivista |
Vai |
| 2004 |
Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits |
Articolo in rivista |
Vai |
| 2004 |
Plasma clearance of human low-density lipoprotein in human apolipoprotein B trangenic mice is related to particle diameter |
Articolo in rivista |
Vai |
| 2004 |
Transient chylomicronemic syndrome: description of three cases |
Abstract in rivista |
Vai |
| 2004 |
LDL size: does it matter ? |
Articolo in rivista |
Vai |
| 2004 |
Stent nudi e stent medicati con sirolimus nel registro RESTEM |
Abstract in rivista |
Vai |
| 2004 |
Use of the drug eluting stents with rapamicin in patients with anatomical or clinical patterns favouring restenosis: results of a 6-months follow-up on the first 100 patients. |
Abstract in rivista |
Vai |
| 2004 |
L’ehrlichiosi: una patologia emergente |
Articolo in rivista |
Vai |
| 2004 |
Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study |
Abstract in rivista |
Vai |
| 2004 |
I LIVELLI DI CISTATINA C SONO RIDOTTI NELL’INFARTO MIOCARDIO ACUTO. EFFETTO DEL POLIMORFISMO G73A SUI LIVELLI PLASMATICI. |
Proceedings |
Vai |
| 2004 |
USE OF THE DRUG ELUTING STENTS WITH RAPAMICIN IN PATIENTS WITH ANATOMICAL OR CLINICAL PATTERNS FAVOURING RESTENOSIS: RESULTS OF A 6-MONTHS FOLLOW-UP ON THE FIRST 100 PATIENS. |
Proceedings |
Vai |
| 2004 |
The malnutrition in the elderly: a clinical approach. |
Articolo in rivista |
Vai |
| 2004 |
Risultati del follow-up di 6 mesi in 100 pazienti con stent medicato con rapamicina rispetto ad altri 100 con stent tradizionale |
Abstract in rivista |
Vai |
| 2004 |
PEAK PARTICLE SIZE AND THE EXTENSION OF CORONARY ATHEROSCLEROSIS IN 71 PATIENTS THAT UNDERWENT AN ANGIOGRAPHIC EXAM |
Proceedings |
Vai |
| 2004 |
Dati del follow-up di 6 mesi sui primi 100 pazienti con stent medicati con rapamicina, con situazioni anatomiche e cliniche favorenti la restenosi |
Abstract in rivista |
Vai |
| 2004 |
Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study. Intenational Angiology. 2004. 23(suppl.1) |
Proceedings |
Vai |
| 2004 |
Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events post-PTCA: a 1 year follow-up study |
Abstract in rivista |
Vai |
| 2004 |
Il diabete, la familiarita’ per malattie cardiovascolari e l’estensione della malattia vasale quali predittori degli eventi clinici ad 1 anno di follow-up post-PTCA |
Abstract in rivista |
Vai |
| 2004 |
Infection and inflammation influence the outcome of patients with asymptomatic carotid lesions. Int Angiol. 2004. 23(suppl.1) |
Proceedings |
Vai |
| 2004 |
EFFETTI “BEYOND CHOLESTEROL” DELLE STATINE |
Articolo in rivista |
Vai |
| 2004 |
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam |
Proceedings |
Vai |
| 2004 |
Uso degli stent medicati con rapamicina in pazienti con situazioni anatomiche o cliniche che favoriscono la restenosi: risultati del follow-up di 6 mesi su primi 100 pazienti |
Abstract in rivista |
Vai |
| 2004 |
Hepatic lipase and lipoprotein lipase are affected by combined estrogen+progestin hormone therapy |
Abstract in rivista |
Vai |
| 2004 |
I livelli di cistatina C sono ridotti nell’infarto miocardico acuto. Effetto del polimorfismo G273A sui livelli plasmatici |
Abstract in rivista |
Vai |
| 2004 |
Use of the drug eluting stents with rapamicin in patients with anatomical or clinical patterns favouring restenosis: results of a 6-months follow-up on the first 100 patients |
Abstract in rivista |
Vai |
| 2004 |
Use of the drug eluting stents with rapamicin in patients with anatomical or clinical patterns favouring restenosis: results of a 6-months follow-up on the first 100 patients. Intenational Angiology. 2004. 23(suppl.1) |
Proceedings |
Vai |
| 2004 |
INFECTION AND INFLAMMATION INFLUENCE THE OUTCOME OF PATIENTS WITH ASYMPTOMATIC CAROTID LESIONS |
Proceedings |
Vai |
| 2004 |
La sindrome orticaria-angioedema: una patologia internistica ad espressione cutanea. [Urticaria and angioedema. A general affection rather than a specific cutaneous disease]. |
Articolo in rivista |
Vai |
| 2004 |
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. |
Articolo in rivista |
Vai |
| 2003 |
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. |
Articolo in rivista |
Vai |
| 2003 |
Clinical predictors of adverse events in a 1 year follow-up study post-PCI |
Abstract in rivista |
Vai |
| 2003 |
La vitamina D in pazienti adulti affetti da talassemia major |
Abstract in rivista |
Vai |
| 2003 |
La somministrazione di amfotericina B per via endoarteriosa rappresenta una valida e sicura terapia della mucormicosi |
Proceedings |
Vai |
| 2003 |
La somministrazione di amphotericina B per via endoarteriosa rappresenta una valida e sicura terapia della mucormicosi |
Abstract in rivista |
Vai |
| 2003 |
Differential apolipoprotein(a) isoform expression in heterozygosity is an independent contributor to lipoprotein(a) levels variability |
Articolo in rivista |
Vai |
| 2003 |
Fattori di rischio cardiovascolari, sindrome plurimetabolica e disfunzione endoteliale |
Abstract in rivista |
Vai |
| 2003 |
Saturated and unsaturated free fatty acids (FFA) modulate differently HDL uptake in hepatoma HEPG2 cells |
Abstract in rivista |
Vai |
| 2003 |
Associazione di più fattori di rischio e d’elevati livelli di fibrinogeno e PCR: ruolo predittivo di complicanze vascolari in una popolazione di soggetti con NIDDM |
Abstract in rivista |
Vai |
| 2003 |
Comparison of the effects of metformin and rosiglitazone in anovulatory women with polycystic ovary syndrome (PCOS) |
Abstract in rivista |
Vai |
| 2003 |
Lipoprotein remnants accumulation in end-stage renal disease: evidence of an active role of heparin administration during hemodialysis |
Abstract in rivista |
Vai |
| 2003 |
Su un caso sospetto di schistosomiasi |
Abstract in rivista |
Vai |
| 2003 |
LDL size, density and receptor affinity variation during an oral load in mild hyper-triglyceridemic and normal subjects |
Abstract in rivista |
Vai |
| 2003 |
Accumulation of remnant-like particles in normolipidemic men with premature coronary artery disease |
Abstract in rivista |
Vai |
| 2003 |
Predective role of asymptomatic carotid lesions for cardiovascular and cerebrovascular, fatal and non fatal, events in a 5-years follow-up study |
Abstract in rivista |
Vai |
| 2003 |
Risultati immediati e a lungo termine della valvuloplastica mitralica percutanea: un’esperienza di dieci anni. |
Abstract in rivista |
Vai |
| 2003 |
L’amphotericina B liposomiale somministrata per via endoarteriosa rappresenta una sicura e valida terapia della mucormicosi |
Abstract in rivista |
Vai |
| 2003 |
L’ipertensione è una variabile associata alla presenza di lesioni carotidee, nonché predittiva di eventi avversi durante il follow-up di 5 anni |
Abstract in rivista |
Vai |
| 2003 |
Coronarografia diagnostica e conseguenti scelte terapeutiche dopo l’avvento degli stent alla rapamicina: approccio attuale ed evoluzione degli ultimi dieci anni. |
Abstract in rivista |
Vai |
| 2003 |
Comparison between different mathematical methods to calcolate insulin resistance in women with polycystic ovary syndrome (PCOS) |
Abstract in rivista |
Vai |
| 2003 |
Studio sulla prevalenza di fratture vertebrali e loro identificazione con esame morfometrico e morfometria digitale |
Abstract in rivista |
Vai |
| 2003 |
Low-density-lipoprotein peak particle size in a Mediterranean population. |
Articolo in rivista |
Vai |
| 2003 |
Validita’ clinica dei marker ossei. |
Abstract in rivista |
Vai |
| 2002 |
Levels of b-sitosterol in a sicilian sample of hyper-cholesterolemic patients |
Abstract in rivista |
Vai |
| 2002 |
CD14 C(-260)>T gene polymorphism is not a risk factor for myocardial infarction |
Proceedings |
Vai |
| 2002 |
Low prevalence of the atherogenic small, dense LDL in a mediterranean population. Nutrition, Metabolism and Cardiovascular Diseases |
Abstract in rivista |
Vai |
| 2002 |
Description of a sicilian family with hyper-alpha-lipoproteinemia with deficit of CETP activity |
Abstract in rivista |
Vai |
| 2002 |
Simvastatin reduces the levels of ApoE-containing triglyceride-rich lipoproteins in men with premature coronary artery disease |
Abstract in rivista |
Vai |
| 2002 |
Changes in levels of triglyceride-rich lipoprotein subfractions during dialysis in uremic patients |
Abstract in rivista |
Vai |
| 2002 |
Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project |
Articolo in rivista |
Vai |
| 2002 |
Bassa prevalenza delle LDL aterogene piccole e dense in una popolazione mediterranea |
Abstract in rivista |
Vai |
| 2002 |
Complicazioni intra-ospedaliere in pazienti ipertesi con infarto miocardico acuto: uno studio retrospettivo di tipo caso-controllo |
Abstract in rivista |
Vai |
| 2002 |
Correlazione fra deficit di vit.D monoidrossilata e danno epatico in soggetti talassemici adulti |
Abstract in rivista |
Vai |
| 2002 |
Accumulo di particelle aterogene remnants dopo la dialisi in pazienti uremici |
Abstract in rivista |
Vai |
| 2002 |
Nutritional characteristics of a rural Southern Italy population: the Ventimiglia di Sicilia Project |
Articolo in rivista |
Vai |
| 2002 |
Descrizione di una famiglia siciliana con iper-alfa-lipoproteinemia con deficit di CETP |
Abstract in rivista |
Vai |
| 2002 |
Lesioni carotidee asintomatiche quale marker di futuri eventi cardiovascolari e cerebrovascolari nel follow-up a lungo termine: correlazione con gli indici di flogosi e le infezioni da cytomegalovirus, chlamydia pneumoniae, helicobacter pylori |
Abstract in rivista |
Vai |
| 2002 |
Studio epidemiologico “Ustica”: bassa prevalenza delle LDL aterogene in una popolazione mediterranea |
Abstract in rivista |
Vai |
| 2002 |
Il polimorfismo genico del CD14 C(-260)>T non e’ un fattore di rischio per infarto miocardico acuto |
Abstract in rivista |
Vai |
| 2002 |
Valutazione dell’outcome a distanza post-PTCA: risultati del follow-up ad un anno |
Abstract in rivista |
Vai |
| 2002 |
Asymptomatic carotid lesion as marker of future cerebrovascular and cardiovascular events in the follow-up: correlation with markers of inflammation and the infections from cytomegalovirus, chlamydia pneumoniae, helicobacter pylori |
Abstract in rivista |
Vai |
| 2002 |
La simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura: effetti delle statine “beyond-cholesterol” |
Abstract in rivista |
Vai |
| 2002 |
Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction |
Articolo in rivista |
Vai |
| 2002 |
Il polimorfismo genico CD14 C(-260)>T non e’ un fattore di rischio per infarto miocardico acuto |
Abstract in rivista |
Vai |
| 2002 |
La simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura: effetti delle statine “beyond-cholesterol” |
Abstract in rivista |
Vai |
| 2002 |
Bassa prevalenza delle LDL aterogene piccole e dense in una popolazione mediterranea |
Abstract in rivista |
Vai |
| 2002 |
Clinical predictors of adverse events in a 1 year follow-up study post-PTCA. |
Abstract in rivista |
Vai |
| 2002 |
Effects “beyond-cholesterol” of statins: simvastatin reduces the levels of atherogenic lipoproteins in patients with premature coronary artery disease |
Abstract in rivista |
Vai |
| 2002 |
Fibrinogen as predictor of mortality in a 42-months follow-up after acute myocardial infarction |
Abstract in rivista |
Vai |
| 2002 |
Trombosi portale mesenterica idiopatica in paziente con doppia mutazione eterozigote del gene C677T e del gene A1298C della MTHFR |
Abstract in rivista |
Vai |
| 2002 |
CD14 C(-260)>T gene polymorphism is not a risk factor for myocardial infarction |
Proceedings |
Vai |
| 2002 |
Coronarografia diagnostica: evoluzione temporale in relazione ai progressi della PTCA |
Abstract in rivista |
Vai |
| 2002 |
Su un caso di ascesso epatico in paziente sottoposta a TACE per HCC |
Abstract in rivista |
Vai |
| 2002 |
Effects of dialysis on the cardiovascular risk of uremic patients: increase in levels of remnant particles |
Abstract in rivista |
Vai |
| 2002 |
Effetti “beyond-cholesterol” delle statine: la terapia con simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura |
Abstract in rivista |
Vai |
| 2002 |
Livelli plasmatici di fibrinogeno in soggetti con infarto miocardico acuto: relazione con gli eventi nel follow-up a 42 mesi |
Abstract in rivista |
Vai |
| 2002 |
Febbre di origine sconosciuta (FUO): due casisitiche di una medesima divisione di medicina interna a confronto |
Abstract in rivista |
Vai |
| 2002 |
Livelli di b-sitosterolo in una popolazione siciliana di pazienti ipercolesterolemici |
Abstract in rivista |
Vai |
| 2002 |
Variations in plasma lipids and in the LDL peak particle size after acute myocardial infarction |
Abstract in rivista |
Vai |
| 2002 |
Il fibrinogeno come predittore di mortalita’ in un follow-up di 42 mesi post-infarto miocardico acuto |
Abstract in rivista |
Vai |
| 2001 |
Le variazioni dei valori dell’assetto lipidico durante la risposta di fase acuta post-infarto miocardico acuto sono accompagnate da modifiche nel size delle LDL |
Abstract in rivista |
Vai |
| 2001 |
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size |
Articolo in rivista |
Vai |
| 2001 |
Prevalenza di fattori di rischio e variazione temporale dei parametri lipidici in una serie consecutiva di 350 infarti acuti del miocardio registrati in una unita’ intensiva di Palermo. |
Abstract in rivista |
Vai |
| 2001 |
Andamento nel tempo dell’approccio alla coronarografia diagnostica in relazione ai progressi della PTCA |
Abstract in rivista |
Vai |
| 2001 |
Dati di mortalita’ e morbilita’ del follow-up condotto su 123 pazienti sottoposti ad angioplastica coronarica |
Abstract in rivista |
Vai |
| 2001 |
Chilomicronemia transitoria causa di diabete di tipo I in assenza di markers umorali di autoimmunità in una bambina di nove anni |
Abstract in rivista |
Vai |
| 2001 |
Variazioni delle sottofrazioni delle lipoproteine ricche in trigliceridi durante la dialisi in soggetti uremici |
Abstract in rivista |
Vai |
| 2001 |
Correlazione in 309 pazienti coronaropatici tra i livelli di HDL-colesterolo e l’estensione della coronaropatia |
Abstract in rivista |
Vai |
| 2001 |
Livelli ridotti di cistatina C nell’infarto miocardico acuto vs. angina instabile, aneurisma aortico e controlli normali |
Abstract in rivista |
Vai |
| 2000 |
Treatment of primary hypercholesterolemia: comparison of the effectiveness of different statins |
Abstract in rivista |
Vai |
| 2000 |
Descrizione di un modello minimo per lo studio della cinetica dei chilomicroni dopo pasto grasso |
Abstract in rivista |
Vai |
| 2000 |
Accumulo di VLDL/IDL contenenti ApoE in maschi normolipemici con cardiopatia ischemica precoce |
Abstract in rivista |
Vai |
| 2000 |
Accumulation of ApoE-containing triglyceride-rich lipoproteins in normolipidemic men with premature coronary artery disease |
Proceedings |
Vai |
| 1999 |
Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. |
Articolo in rivista |
Vai |
